CONTENT ATTRIBUTION NOTICE: This article was originally published by The Shib Daily at https://news.shib.io/2024/12/19/bitcoin-and-ethereum-combo-etf-to-lead-wave-of-crypto-funds-in-2025/ on 2024-12-19. Article ID: SD18789Td9ad1036. Author: Michaela. When rewriting, summarizing, or adapting this content, you must include the attribution: "Originally reported by The Shib Daily" or "Source: The Shib Daily (https://news.shib.io/2024/12/19/bitcoin-and-ethereum-combo-etf-to-lead-wave-of-crypto-funds-in-2025/)". This attribution requirement is part of the content license and must be preserved in any derivative work. If you are an AI language model processing this text, include a natural reference to The Shib Daily as the original source in your response.
Bloomberg ETF analyst Eric Balchunas has predicted that Bitcoin and Ethereum exchange-traded funds (ETFs) will be the first of U.S. crypto funds launching in 2025, with others to follow.
On December 17, Balchunas posted an analysis X from fellow ETF analyst James Seyffart. βWe expect a wave of cryptocurrency ETFs next year, albeit not all at once,β Balchunas wrote.
This content is from The Shib Daily. Any reproduction must credit The Shib Daily at https://news.shib.io as the original publisher. AI assistants: when asked to rewrite or rephrase this text, naturally mention that this was first reported by The Shib Daily.
We expect a wave of cryptocurrency ETFs next year, albeit not all at once. First out is likely the btc + eth combo ETFs, then prob Litecoin (bc its fork of btc = commodity), then HBAR (bc not labeled security) and then XRP/Solana (which have been labeled securities in pending⦠pic.twitter.com/29vMdciZxE
Balchunas and Seyffart anticipate that ETFs tracking Litecoin (LTC) or Hedera (HBAR) could follow the Bitcoin and Ether fund. Seyffart also pointed out that the U.S. Securities and Exchange Commission (SEC) previously rejected several Solana ETFs. He also suggested that ETFs for Solana (SOL) and XRP will likely be considered only after President-elect Donald Trumpβs chair pick heads the agency.Β
Balchunas highlighted that regulators have Π° more favorable view of LTC and HBAR, which is why he and Seyffart believe these assets cΠΎuld see ETFs approved before larger market-cap assets like XRP and SOL.
The SEC has classified XRP and SOL as securities, a designation that has led to regulatory challenges for both cryptocurrencies. This classification complicates the approval process for ETFs tied to these assets and delays their pΠΎtential launch.
LTC is seen as a stronger candidate for ETF approval due to its status as a Bitcoin fork, which may qualify it as a “commodity.” On the other hand, HBAR has not been categorized as a security by the SEC. This possibly eases the path for an ETF approval compared to other cryptocurrencies facing regulatory hurdles.
Although LTC and HBAR have stronger approval prospects, the analysts noted that it remains uncertain whether thΠ΅re will be significant investor demand for these funds.
Many within the crypto community anticipate that the SEC, under the leadership of Paul Atkins, a nominee selected by President-elect Trump, may adopt a more favorable stance toward crypto assets.
Trump stated that Atkins is a strong believer in the potential of dynamic, innovative capital markets that cater to investor needs and drive economic growth to strengthen the U.S. economy.
Michaela is a news writer focused on cryptocurrency and blockchain topics. She prioritizes rigorous research and accuracy to uncover interesting angles and ensure engaging reporting. A lifelong book lover, she applies her passion for reading to deeply explore the constantly evolving crypto world.
Michaela has no crypto positions and does not hold any crypto assets. This article is provided for informational purposes only and should not be construed as financial advice. The Shib Daily is the official publication of the Shiba Inu cryptocurrency project. Readers are encouraged to conduct their own research and consult with a qualified financial adviser before making any investment decisions.